Navigation Links
Guava EasyCyte Mini from Guava Technologies

ProductsGuava EasyCyte Mini from Guava Technologies
Company Guava Technologies
Item Guava EasyCyte Mini
Price 
Description Once again Guava is making flow cytometry accessible to anyone in the lab. Novice and experts alike will appreciate the latest addition to Guavas on-demand microcapillary flow cytometry systems the Guava EasyCyte Mini easy to use, surprisingly affordable, very compact, and nicely equipped with a blue laser and 3-color detection. The Guava EasyCyte Mini has all of the functionality of the current Guava EasyCyte 96-well platform but in a single sample format, making the system extremely affordable and accessible to those researchers with lower throughput needs.

The Guava EasyCyte Mini runs each of Guavas turnkey assays, enabling easy, fast measurements of GFP expression and viability, cell counting/viability, apoptosis, cell cycle analysis, antigen detection and more. Assays require only micro-volumes of cells and reagents, and the system generates minimal waste. In addition, like all of the Guava systems, the unique ability to obtain direct absolute cell counts, in addition to population percentages, allows researchers to monitor increases or decreases in overall cell number which may have an impact on their assay. This functionality cannot be obtained with traditional sheath flow cytometers.

System Components:
Automated analyzer unit with internal hard drive Single sample, tube format Flat screen monitor Wireless keyboard with trackball and optional mouse CytoSoft Software with expandable software modules

EasyCyte Mini Specifications:
  • Dimensions: 9" (23cm) h x 15.5" (39 cm) w x 18" (46 cm) d
  • Weight: 50 lbs (22.7 kg)
  • Light scatter: Forward; side (optional)
  • Sample format: 1.2 or 1.5 ml tubes
Info Guava TechnologiesGuava Technologies
25801 Industrial Boulevard
Hayward , CA 94545-2991

Customer Service: 888.448.2827
Fax Number: 510.576.1500
Web Site: http://www.guavatechnologies.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. EasyCyte Plus System from Guava Technologies
2. Guava® Personal Cell Analysis 96 System from Guava Technologies
3. Guava EasyCyte from Guava Technologies
4. S. pombe Whole Genome ChIP-on-chip from Agilent Technologies
5. S. cerevisiae yeast Whole Genome from Agilent Technologies
6. S. cerevisiae yeast Whole Genome from Agilent Technologies
7. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Human Placenta from OriGene Technologies
8. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Human Heart from OriGene Technologies
9. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Mouse Testis from OriGene Technologies
10. F-7000 Research Grade Fluorescence Spectrophotometer from Hitachi High Technologies America
11. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Mouse Brain (adult) from OriGene Technologies
... Microarrays designed for pathway studies, ... protein (PTB) Studies built on the ... synthesis platform. These microarrays are available ... Peptide Microarray Service. Custom ...
... normal Mega Western Protein Array was developed ... Western Protein Arrays are manufactured using high ... sources. A protein sample from each of ... a Protein molecular weight marker on a ...
... Superior Protein Detection and Quantitation Over ... Proteomic Imaging System is a highly sensitive ... life science research applications. ProXPRESS 2D provides ... dyes in the UV and VIS spectrum ...
... 7 lanes of total ... brain tissue including: precentral ... lobe, temporal lobe, parietal ... cerebellum. Patent/trademark/license (electronic): Manufactured ...
Biology Products:
(Date:7/31/2014)... By tracing nearly 3,000 genes to the earliest ... Florida scientists have created an extensive "Tree of ... next-generation DNA sequencing. , Among the study,s ... to small moths than to large ones, which ... The study also found that some insects once ...
(Date:7/31/2014)... (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity ... (HPV) vaccine Cervarix. Women vaccinated with the ... than nine years, and vaccine efficacy (VE) ... the longest follow-up report for a licensed ... the full paper. , HPV and ...
(Date:7/31/2014)... German . ... to a sponge that soaks up liquids. Hence, these ... greenhouse gases. However, loading of many MOFs is inhibited ... now report in Nature Communications that the ... This can be prevented by water-free synthesis and storing ...
Breaking Biology News(10 mins):UF study advances 'DNA revolution,' tells butterflies' evolutionary history 2UF study advances 'DNA revolution,' tells butterflies' evolutionary history 3Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 3Free pores for molecule transport 2
... its fluid membranes to carry out critical ... or sorting proteins.,Because membranes are fluid and ... in detail has always been,difficult. But a ... of physics at Carnegie Mellon University, provides ...
... Carbon nanotubes are 10,000 times thinner than a human ... diamonds. They conduct heat and electricity with efficiency that ... in everything from concrete and clothes to bicycle parts ... wonder material for what could become a multi-billion dollar ...
... crops have been widely adopted by American farmers. In ... European Union (EU) imposed a 6-year freeze (19982004) on ... aid to African nations was rejected by the recipient ... contributed to this decision. , Lori Unruh Snyder, Department ...
Cached Biology News:Carnegie Mellon develops computer model to study cell membrane dynamics 2Carnegie Mellon develops computer model to study cell membrane dynamics 3Making sure the wonder materials don't become the wonder pollutant 2
(Date:7/31/2014)... (PRWEB) July 31, 2014 The global ... 8,020.1 million by 2020, according to a new study ... medicine and theranostics, and the subsequent introduction of advanced ... driving market growth over the next six years. Moreover, ... diseases such as cancer, coupled with disease triggering lifestyle ...
(Date:7/31/2014)... Wash. , July 31, 2014   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... media and precision thermal shipping products for ... second quarter 2014 financial results will be released on ... host a conference call and live webcast at 4:30 ...
(Date:7/31/2014)... MA (PRWEB) July 31, 2014 Boston’s ... finds itself flush with innovative adult stem cell biotechnologies. ... patents and has three additional patent applications currently ... , The patented inventions address two of the most ... regenerative medicine. Adult stem cells are difficult to ...
(Date:7/30/2014)... TARRYTOWN, N.Y. and PARIS ... REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today ... Food and Drug Administration (FDA) rare pediatric disease priority ... (BLA) submission for alirocumab.  The priority review voucher entitles ... which provides for an expedited 6-month review from the ...
Breaking Biology Technology:Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 2Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 3Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 5BioLife Solutions to Report Financial Results for Second Quarter 2014 and Provide Business Update on August 7, 2014 2The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies 2The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 5Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 6